FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| QuVa Pharma | 079937015 | Fentanyl Citrate; Bupivacaine Hydrochloride | 200 ug/100 mL; 100 mg/100 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate; Bupivacaine Hydrochloride | 200 ug/100 mL; 62500 ug/100 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate; Bupivacaine Hydrochloride | 200 ug/100 mL; 125 mg/100 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate; Bupivacaine Hydrochloride | 800 ug/200 mL; 333.4 mg/200 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate; Bupivacaine Hydrochloride | 200 ug/100 mL; 100 mg/100 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate; Bupivacaine Hydrochloride | 500 ug/250 mL; 312.5 mg/250 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate; Bupivacaine Hydrochloride | 500 ug/250 mL; 250 mg/250 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate; Ropivacaine Hydrochloride | 400 ug/200 mL; 200 mg/200 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate; Ropivacaine Hydrochloride | 200 ug/100 mL; 200 mg/100 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Amiodarone Hydrochloride | 900 mg/500 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate; Ropivacaine Hydrochloride | 400 ug/200 mL; 200 mg/200 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate; Ropivacaine Hydrochloride | 500 ug/250 mL; 500 mg/250 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate; Ropivacaine Hydrochloride | 500 ug/250 mL; 500 mg/250 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Fentanyl Citrate; Ropivacaine Hydrochloride | 300 ug/150 mL; 300 mg/150 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Amiodarone Hydrochloride | 450 mg/250 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Furosemide | 100 mg/100 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Glycopyrrolate | 1 mg/5 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Glycopyrrolate | 1 mg/5 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Glycopyrrolate | 1 mg/5 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Glycopyrrolate | 1 mg/5 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Glycopyrrolate | 1 mg/5 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Heparin Sodium | 2500 U/5 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Heparin Sodium | 6000 U/3 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Heparin Sodium | 5000 U/1000 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Heparin Sodium | 30000 U/1000 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Heparin Sodium | 50 U/50 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Heparin Sodium | 20 U/20 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Heparin Sodium | 4000 U/1000 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Heparin Sodium | 5000 U/500 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Heparin Sodium | 4000 U/1000 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Heparin Sodium | 12 U/48 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Hydromorphone Hydrochloride | 30 mg/30 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Hydromorphone Hydrochloride | 20 mg/100 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Hydromorphone Hydrochloride | 6 mg/30 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Hydromorphone Hydrochloride | 1 mg/5 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Hydromorphone Hydrochloride | 20 mg/100 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Hydromorphone Hydrochloride | 1 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Hydromorphone Hydrochloride | 50 mg/50 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Hydromorphone Hydrochloride | 2 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Hydromorphone Hydrochloride | 25 mg/50 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Hydromorphone Hydrochloride | 10 mg/50 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Hydromorphone Hydrochloride | 50 mg/50 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Hydromorphone Hydrochloride | 15 mg/30 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Hydromorphone Hydrochloride | 10 mg/50 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Hydromorphone Hydrochloride | 5 mg/25 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Hydromorphone Hydrochloride | 6 mg/30 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Ketamine Hydrochloride | 50 mg/5 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Atropine Sulfate | 1 mg/2.5 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Ketamine Hydrochloride | 50 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | |||
| QuVa Pharma | 079937015 | Atropine Sulfate | 2 mg/5 mL | 2019-1 | source_no_ndc | 2026-11-14 |